Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease (2020)
- Authors:
- USP affiliated authors: LANCHOTE, VERA LUCIA - FCFRP ; DANTAS, MARCIO - FMRP ; COELHO, EDUARDO BARBOSA - FMRP ; PEREIRA, MARIA PAULA MARQUES - FCFRP ; NARDOTTO, GLAUCO HENRIQUE BALTHAZAR - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1002/jcph.1485
- Subjects: NEFROPATIAS; INTERAÇÃO ENTRE ALIMENTOS E MEDICAMENTOS; FARMACOCINÉTICA
- Keywords: Carvedilol; Chronic kidney disease; Drug-drug interaction; Enantiomers; Lercanidipine; Pharmacokinetics
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: The Journal of Clinical Pharmacology
- ISSN: 1552-4604
- Volume/Número/Paginação/Ano: v. 60, n. 1, p. 75-85, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SCHAAB, Estela Hanauer et al. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, v. 60, n. 1, p. 75-85, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1485. Acesso em: 03 jun. 2024. -
APA
Schaab, E. H., Lanchote, V. L., Nardotto, G. H. B., Pereira, M. P. M., Dantas, M., Paiva, C. E., & Coelho, E. B. (2020). Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease. The Journal of Clinical Pharmacology, 60( 1), 75-85. doi:10.1002/jcph.1485 -
NLM
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.1485 -
Vancouver
Schaab EH, Lanchote VL, Nardotto GHB, Pereira MPM, Dantas M, Paiva CE, Coelho EB. Effect of lercanidipine on the pharmacokinetics-pharmacodynamics of carvedilol enantiomers in patients with chronic kidney disease [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 1): 75-85.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.1485 - Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats
- Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry
- Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients
- Influence of glomerular filtration rate on the pharmacokinetics of cyclophosphamide enantiomers in patients with lupus nephritis
- Enantioselective pharmacokinetics of lercanidipine in healthy volunteers
- Influence of lercanidipine in the kinetic sisposition of fluvastatin enantiomers in healthy volunteers
- Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics
- Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
Informações sobre o DOI: 10.1002/jcph.1485 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003004811.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
